Ken Griffin Stereotaxis, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$1.73 - $3.2 $8,823 - $16,320	5,100 Added 83.61%	11,200 $20,000
Q1 2024 May 15, 2024	BUY	$1.74 - $3.16 $348 - $632	200 Added 3.39%	6,100 $15,000
Q4 2023 Feb 14, 2024	BUY	$1.42 - $1.96 $6,958 - $9,604	4,900 Added 490.0%	5,900 $10,000
Q3 2023 Nov 14, 2023	SELL	$1.42 - $1.84 $9,798 - $12,696	-6,900 Reduced 87.34%	1,000 $1,000
Q2 2023 Aug 14, 2023	BUY	$1.51 - $2.27 $2,114 - $3,178	1,400 Added 21.54%	7,900 $12,000
Q1 2023 May 15, 2023	SELL	$1.85 - $2.71 $6,660 - $9,756	-3,600 Reduced 35.64%	6,500 $13,000
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.38 $102,145 - $156,842	-65,900 Reduced 86.71%	10,100 $20,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $2.62 $2,100 - $3,144	1,200 Added 1.6%	76,000 $137,000

41.1M

413K

26.3K

Ticker STXS
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,790,096
Market Cap $145M
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.